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ABSTRACT
Human genome stability requires efficient repair of
oxidized bases, which is initiated via damage recog-
nition and excision by NEIL1 and other base excision
repair (BER) pathway DNA glycosylases (DGs). How-
ever, the biological mechanisms underlying detec-
tion of damaged bases among the million-fold excess
of undamaged bases remain enigmatic. Indeed, mu-
tation rates vary greatly within individual genomes,
and lesion recognition by purified DGs in the
chromatin context is inefficient. Employing super-
resolution microscopy and co-immunoprecipitation
assays, we find that acetylated NEIL1 (AcNEIL1), but
not its non-acetylated form, is predominantly local-
ized in the nucleus in association with epigenetic
marks of uncondensed chromatin. Furthermore,
chromatin immunoprecipitation followed by high-
throughput sequencing (ChIP-seq) revealed non-
random AcNEIL1 binding near transcription start
sites of weakly transcribed genes and along highly
transcribed chromatin domains. Bioinformatic anal-
yses revealed a striking correspondence between
AcNEIL1 occupancy along the genome and muta-
tion rates, with AcNEIL1-occupied sites exhibiting
fewer mutations compared to AcNEIL1-free domains,
both in cancer genomes and in population variation.
Intriguingly, from the evolutionarily conserved un-
structured domain that targets NEIL1 to open chro-
matin, its damage surveillance of highly oxidation-
susceptible sites to preserve essential gene function
and to limit instability and cancer likely originated
∼500 million years ago during the buildup of free at-
mospheric oxygen.
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INTRODUCTION
It is estimated that ∼70 000 lesions occur in genomic DNA
in each human cell per day, most of which (75%) originate
from oxidation reactions with endogenous byproducts of
metabolism and base hydrolysis (1). To counteract the con-
tinuous threat these lesions pose to genome stability, cells
have evolved a wide-ranging arsenal of repair programs,
including DNA base excision repair (BER), mismatch re-
pair (MMR), nucleotide excision repair (NER), transle-
sion synthesis (TLS) and strand break repair (homologous
recombination and various non-homologous end joining
pathways), which together act upon particular types of le-
sion or at specific phases of the cell cycle to prevent mu-
tations in DNA and cell death. Oxidative stress induces a
plethora of small base modifications, including the stable
2′-deoxycytidine derivatives 5-hydroxy-2′-deoxycytidine, 5-
hydroxy-2′-deoxyuridine and 5,6-dihydroxy-5,6-dihydro-2′-
deoxyuridine, and the 2′-deoxyguanosine base 8-oxo-7,8-
dihydro-2′-deoxyguanosine (8-oxoG), which accumulate at
sufficiently high rates in human tissues to be readily de-
tected (2). If not removed, these lesions are potentially mu-
tagenic since replicative DNA polymerases, although pos-
sessing high fidelity, are not able to discriminate between a
canonical and a noncanonical incoming base during DNA
synthesis, thereby giving rise to mismatches that are then
fixed into mutations at the next round of replication. Oxi-
dized nucleotide pools are also mutagenic as they are readily
incorporated into nascent DNA.
Oxidative lesions and selected mismatches are primar-
ily repaired by BER, which is initiated by recognition and
cleavage by one of several DNA glycosylases (DGs) (mono-
functional: MBD4, MYH, MPG, SMUG1, TDG, UDG;
bifunctional: OGG1, NTH1 and NEIL1/2/3) to generate
an apurinic/apyrimidinic (AP) site processed, in the case of
monofunctional enzymes, by AP endonuclease 1 (APE1),
yielding a single-strand break (3–6). Full reconstitution of
the original DNA sequence then proceeds through either
short or long patch repair, which minimally requires DNA
synthesis (Pol , Pol  and Pol ε) across the break followed
by ligation (Lig1 and Lig3) (7–10)).
Structural analyses of BER initiation regions in the
genome have revealed detection of local base damage by ac-
tive surveillance of intact DNA helices by DGs (5,11–12)
followed by concerted steps, whereby one enzyme channels
its product to the next enzyme in the pathway (13,14). How-
ever, the efficient global mechanisms through which dam-
aged bases are robustly detected within the vast excess of
unmodified bases, particularly in the context of chromatin,
have remained largely enigmatic. Indeed, whereas on naked
DNA DGs are capable of interrogating helix integrity via
effective mechanisms, including sliding, hopping and jump-
ing, damage recognition in the context of reconstituted nu-
cleosomal DNA is highly inefficient (reviewed in (7,9,15–
16)).
Recent findings have implicated posttranslational mod-
ification (PTM) of BER factors in the assembly of active
‘BERosome’ complexes onto chromatin, thereby promot-
ing the concept that reversible PTM may be critical for me-
diating and regulating protein-protein interactions among
DNA repair factors, modified histones and other chromatin
remodeling factors in the cell (17–22). However, as only
very few ChIP-seq analyses of BER components are avail-
able, the extent to which these factors share genomic space
has not been addressed. This question is intriguing given
that the composition and PTM landscape differ in differ-
ent regions of the genome, so would BERosome assembly
along the genome, potentially leading to local variations in
BER and hence mutation rates. Indeed, despite the fact that
replication-associated mutations have been linked to high
frequencies of single base-pair substitutions (SBSs) in hu-
man cancers (23), mutational landscapes in cancer genomes
are highly heterogeneous (24,25). In fact, it has been noted
that both in cancer and in the context of human popula-
tion variation, mutation rates are lower in early replicating
euchromatic regions than in late replicating compact hete-
rochromatic regions (reviewed in (26)), raising questions as
to the underlying mechanisms.
Here we examined human Nei-like-1 (NEIL1), a proto-
typic DG that initiates BER by excising oxidized base le-
sions in both double-stranded and single-stranded DNA
(27,28). Motivated by our recent study showing significantly
higher BER activity of acetylated (AcNEIL1) compared to
nonacetylated NEIL1 (17), we determined their localiza-
tion. We found that contrary to total NEIL1, which punc-
tuates uniformly both nuclei and cytoplasm, AcNEIL1 is
mostly confined to nuclei from where it can be readily iso-
lated in complex with RNA pol II and other components
of the active chromatin. We showed that NEIL1 becomes
stabilized on chromatin after site-specific (Lys296–298) acety-
lation, and accumulates almost exclusively at highly tran-
scribed genomic regions as well as the transcription start
sites (TSS) of weakly expressed genes, some of which are
associated with poor prognosis when overexpressed in can-
cer. Bioinformatic analyses using cancer genome datasets
and human germline population mutation datasets provide,
with unprecedented resolution, information on the rela-
tionship between local variations in single base substitu-
tion (SBS) rates and ChIP-seq AcNEIL1 occupancy, both
in cancer genomes and the germline. The AcNEIL1 acety-
lation center appears to have consolidated from variable
amino acids in protostomes ∼540 million years ago, dur-
ing a transition from sulfur to oxygen as an energy source.
By combining our results with available data, we conclude
that AcNEIL1-containing BERosomes are stabilized onto
chromatin through PTM, where they are poised for lesion
recognition and repair in areas of the genome which, be-
cause of high transcription, are particularly vulnerable to
oxidative damage.
MATERIALS AND METHODS
Cell lines and treatments
The human colorectal adenocarcinoma HCT116 (ATCC #
CCL-247), human ovarian cancer SKOV3 (ATCC # HTB-
77), and human osteosarcoma U2OS (ATCC # HTB-96)
cell lines were grown in McCoy’s 5A medium (Gibco/Life
Technologies). The human cervical adenocarcinoma HeLa
(ATCC #CCL2) and human embryonic kidney epithelial
HEK293 (ATCC # CRL-1573) cell lines were maintained
in DMEM-high glucose medium (Hyclone). Human breast
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cancer MDA-MB-231 (ATCC # HTB-26), human acute
leukemia Jurkat (ATCC # TIB-152) and human lung can-
cer H1563 (ATCC # CRL-5875) cells were maintained in
RPMI 1640 medium (Corning). Human prostate cancer
PC3 (ATCC # CRL-1435) cells were cultured in F-12K
Medium (Corning). The human lymphoblast K562 (ATCC
# CCL-243) and the near-haploid human HAP1 (Hori-
zon) cells were maintained in Iscove’s Modified Dulbecco’s
Medium (Corning). All culture media were supplemented
with 10% fetal bovine serum (FBS, Sigma-Aldrich) and
1% (v/v) penicillin/streptomycin (Life Technologies). The
cells were maintained in a humidified incubator at 37◦C
with 5% CO2. Exponentially growing cells were treated
with 1 M retinoic acid (RA; Sigma) according to exper-
iments for mRNA expression and ChIP assays. Downregu-
lation of endogenous NEIL1 was carried out by Lipofec-
tamine RNAimax-mediated transfection of HCT116 and
HeLa cells with NEIL1-specific siRNA (Sigma; sense: 5′CC
GUGAUGAUGUUUGUUUAUU3′; antisense: 5′UAAA
CAAACAUCAUCACGGUU3′) or the universal negative
control siRNA (Sigma; # SIC001) following the manufac-
turer’s protocol. The inhibition of NEIL1 acetylation and
deacetylation was achieved by treating HCT116 cells with
DMSO (control), the histone acetyltransferases (HAT, such
as p300 and PCAF) inhibitor Garcinol (50 and 10 M;
Santa Cruz Biotech), and the histone deacetylase (HDAC)
inhibitor nicotinamide (NAM) (2 and 0.2 mM; Sigma), re-
spectively.
Chromatin fractionation
Subcellular fractionation for chromatin extracts from
HCT116 cells was performed following our previously pub-
lished protocol with slight modifications (17). Briefly, 80–
90% confluent HCT116 cells grown in 150 cm plates were
washed twice in DPBS, and then lysed in ice-cold cytoplas-
mic lysis buffer (10 mM Tris–HCl pH 7.9, 0.34 M sucrose,
3 mM CaCl2, 2 mM MgCl2, 0.1 mM ethylenediaminete-
traacetic acid (EDTA), 1 mM 1,4-dithiothreitol (DTT),
0.1% NP-40 and cocktail protease inhibitors (Thermo Sci-
entific); 750 l lysis buffer per 150 cm plate). After pellet-
ing the nuclei by centrifugation at 3500 g for 15 min at 4◦C,
pellets were lysed in ice-cold nuclear lysis buffer (20 mM
HEPES pH 7.9, 1.5 mM MgCl2, 3 mM EDTA, 150 mM
K-acetate, 10% glycerol, 0.5% NP-40 and cocktail protease
inhibitors; 200 l lysis buffer per 150 cm plate), vortexed for
15 min at 4◦C, followed by centrifugation at 14 000 rpm for
15 min at 4◦C to pellet the chromatin. The supernatant was
labeled as the soluble nuclear extract. The chromatin pel-
let was dissolved in chilled chromatin lysis buffer (150 mM
HEPES pH 7.9, 1.5 mM MgCl2, 150 mM K-acetate, 10%
glycerol and cocktail protease inhibitors; 150 l lysis buffer
per 150 cm plate), and incubated with 0.15 unit/l of Ben-
zonase (Novagen) at 37◦C for 30 min, followed by centrifu-
gation at 14 000 rpm for 15 min at 4◦C. The supernatants
(chromatin extracts) were collected for western blotting.
Antibodies
The following antibodies were used: -H3 (Cell Signaling;
#4499), -H3K27Ac (Active Motif; #39685), -H3K27Ac
(Cell Signaling; 8173), -H4K16Ac (Active Motif; #61529),
-H4K16Ac (Cell Signaling; #13534), anti-G-quadruplex
DNA 1H6 (Millipore; #MABE1126), -MeCP2 (AbCam;
#ab2828), -Pan-Methyl-H3K9 (Cell Signaling; #4473), -
methyl-histone H3K9 (Cell Signaling; #5327), -RNA Pol
II (Santa Cruz Biotechnology; #sc-899), -APE1 (Novus
Biologicals; #NB100-116). The -NEIL1 antibody was as
in (28); the -AcNEIL1 antibody was custom-generated
through EZBiolab using a chemically synthesized NEIL1
peptide (288APKGRKSRK*K*K*SKA301) with acetylated
Lys (*) as hapten to induce IgG antibody in rabbit, as pre-
viously described (17).
Cytospin
Cells were harvested and washed twice with ice-cold
phosphate-buffered saline (PBS); 1 × 105 cells were resus-
pended in 200 L cold PBS containing 10% FBS. The cell
suspension was added to the cytospin apparatus, followed
by centrifugation at 800 rpm for 5 min (Shandon Cytospin 4
cytocentrifuge; Thermo Scientific). After removal from cen-
trifugation, slides were dried at room temperature and fixed
with 4% paraformaldehyde (PFA) for immunofluorescence
staining.
Immunofluorescence and imaging
HCT116 cells were cultured onto glass coverslips and grown
for 24 h (75% confluence), washed twice with PBS and fixed
for 20 min with 4% paraformaldehyde at room temperature.
Then cells were washed with PBS and permeabilized with
0.1% saponin for 30 min in PBS, and subsequently blocked
in 2% BSA blocking buffer for 1 h. Next, cells were stained
with primary antibodies overnight at 4◦C. Coverslips were
rinsed five times with PBS and subsequently incubated with
anti-Rabbit IgG Atto 488 (Sigma-Aldrich; #18772) and
anti-Mouse IgG Atto 555 (Sigma-Aldrich; #43394) (1:200)
for 1 h at room temperature followed by further five washes
in PBS. Cells were then incubated with or without 100 nM
Acti-stain™670 phalloidin (Cytoskeleton, Inc) for another
30 min. After washing with PBS five times, coverslips were
mounted on glass slides by using DAPI-containing mount-
ing media (Invitrogen) and analyzed by an LSM710 confo-
cal microscope (Carl Zeiss AG).
ChIP assays
Direct ChIP assays. ChIP assays were performed on
exponentially growing cells (one 70–80%-confluent 10-cm
plate for one ChIP reaction) with Magna ChIP Protein
A/G magnetic beads (Millipore, # 16-663) using the
custom-generated rabbit -AcNEIL1 antibody, rabbit
-H3K27Ac (Cell Signaling; 8173) antibody, or control
IgG as described below. After washing in PBS, cells were
crosslinked with 1% formaldehyde (15 min at room tem-
perature) in PBS. Crosslinked cells were washed three times
in PBS and scraped off the plates into PBS containing a
protease inhibitor (PI) cocktail (Thermo Scientific/Pierce;
# 88666) and pelleted at 900 RPM (10 min, 4◦C). Pelleted
cells were lysed in sodium dodecyl sulphate (SDS) lysis
buffer (1% SDS, 10 mM EDTA, 50 mM Tris–HCl pH
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8, and PI), incubated on ice for 10 min and subjected to
sonication (XL-2000 QSonica LLC) on ice, setting the
pulse at 4 for 4–5 times with a 1 min interval in between,
followed by centrifugation (14,000 RPM, 15 min, 4◦C) to
collect the sheared chromatin lysate. IP was performed in
this chromatin lysate with 30 l Protein A/G magnetic
beads, the corresponding antibody (5 g; control IgG was
included in a separate IP) in a total volume of 2 ml (diluted
1:10 with ChIP dilution buffer: 0.01% SDS, 1.1% Triton
X-100, 1.2 mM EDTA, 16.7 mM Tris–HCl, pH 8.1, 167
mM NaCl, PI) overnight (4◦C) with constant shaking.
The next day, the IPs were washed sequentially with low
salt immune complex wash buffer (0.1% SDS, 1% Triton
X-100, 2 mM EDTA, 20 mM Tris–HCl, pH 8, 150 mM
NaCl), high salt immune complex wash buffer (0.1% SDS,
1% Triton X-100, 2 mM EDTA, 20 mM Tris–HCl, pH 8,
500 mM NaCl), LiCl immune complex wash buffer (0.25
M LiCl, 1% NP40, 1% Na-deoxycholate, 1 mM EDTA,
10 mM Tris–HCl, pH 8) and TE buffer (10 mM Tris–HCl,
1 mM EDTA, pH 8). The protein–DNA complexes were
eluted in ChIP elution buffer (1% SDS, 0.1 M NaHCO3),
de-crosslinked in 200 mM NaCl for 4 h at 65◦C. ChIP
DNA was purified by proteinase K digestion, RNAse
treatment, phenol chloroform extraction and ethanol
precipitation using standard protocols. The ChIP-purified
DNA was finally dissolved in 10 mM Tris–HCl pH 8.
The ChIP and 10% input DNA were subjected to SYBR
GREEN-based quantitative polymerase chain reaction
(qPCR) (7500 real-time PCR system; Applied Biosystems)
with primers (Supplementary Table S2) and SYBR Premix
Ex Taq (TaKaRa). Data are represented as percentage
input according to http://www.lifetechnologies.com/us/
en/home/life-science/epigenetics-noncoding-rna-research/
chromatin-remodeling/chromatin-immunoprecipitation-
chip/chip-analysis.html.
ChIP-seq assays. For ChIP-seq assays, the direct ChIP
protocol above was followed with the following modifica-
tions: about 70%-confluent exponentially growing HCT116
cells in 10-cm plates (10–15 plates) were pelleted after
crosslinking and PBS wash. Hypotonic lysis buffer (20 mM
HEPES pH 7.9. 10 mM KCl, 1 mM EDTA, 10% glycerol,
1 mM DTT, PI) was added to the cell pellet, followed by in-
cubation on ice for 15 min. Cells were then centrifuged at
900 RPM (10 min, 4◦C), and RIPA buffer (10 mM Tris–
HCl pH 8, 140 mM NaCl, 1% Triton-X 100, 0.1% SDS,
1% sodium deoxycholate, 1 mM DTT, PI) was added to
the pellet, incubated on ice for 10 min to extract the nu-
clear lysate, which was sonicated 12 times. IP was carried
out in the sheared chromatin lysate with 80 l protein A/G
magnetic beads, the corresponding antibody (10 g; con-
trol IgG was included in a separate IP) in a total volume
of 3–4 ml (diluted with ChIP dilution buffer) overnight at
4◦C with constant shaking. Next day, the IPs were washed
three times with RIPA buffer, then with PBS and finally
with TE buffer. The protein-DNA complexes were eluted
in ChIP elution buffer, de-crosslinked and finally the ChIP-
ed DNA was purified by proteinase K digestion, RNAse
treatment, phenol chloroform extraction and ethanol pre-
cipitation. The ChIP-purified DNA was finally dissolved in
10 mM Tris–HCl pH 8 and subjected to next-generation se-
quencing (NGS) on an Illumina HiSeq 4000 sequencer per-
forming a 76-nt paired-end sequencing read format. ChIP
DNA was quantified by Nanodrop Spectrophotometer and
then used to create an NGS library following the TruSeq v2
(Illumina) protocol.
Co-IP assays
Co-IP assays were performed using nuclear extracts from
HCT116 cells. Exponentially growing cells were first lysed
in cytoplasmic lysis buffer (10 mM Tris–HCl pH 8, 0.34
M sucrose, 3 mM CaCl2, 2 mM MgCl2, 0.1 mM EDTA,
1 mM DTT, 0.1% Nonidet P-40 and PI) and nuclei were
pelleted by centrifugation at 4000 RPM for 15 min at 4◦C.
Nuclear pellets were lysed in cell lysis buffer (50 mM Tris–
HCl pH 7.5, 150 mM NaCl, 1 mM EDTA, 1% Triton-X,
PI), followed by vortexing for 15 min at 4◦C, and centrifu-
gation at 14 000 RPM for 30 min at 4◦C. The supernatant
was the nuclear extract. The nuclear lysates were precleared
by incubating with IgG and protein A (Millipore; 16-661)
or protein A/G magnetic beads for 1 h at 4◦C with con-
stant shaking. The precleared lysates after separating from
the magnetic beads were incubated overnight with the cor-
responding antibody (or IgG) and fresh protein A or A/G
magnetic beads at 4◦C with constant shaking. Next day,
the beads were washed sequentially three times with Tris
buffered saline (TBS) containing 0.05% Tween 20, followed
by sequentially low salt, high salt, immune complex and TE
wash buffers. The washed beads were eluted in Laemmli
buffer followed by SDS-polyacrylaminde gel electrophore-
sis (PAGE) for Western blot analysis with the appropriate
antibodies.
Real time RT-PCR assays
Total RNA from control and experimental cells was isolated
with Qiagen RNeasy mini kit including on-column DNase1
digestion and processed for cDNA synthesis using the Su-
perscript III first-strand synthesis kit (Invitrogen), follow-
ing the manufacturer’s protocol. RARβ2 expression levels
were analyzed in samples with SYBR GREEN-based Real
Time PCR and specific primers (Supplementary Table S2),
using HPRT1 as an internal control. Data were represented
as relative quantitation with respect to the reference sam-
ples set at 1 based on the 2−CT method.
Cell imaging
HCT116 cells were grown on coverslip, fixed by the addi-
tion of 4% (w/vol) paraformaldehyde (PFA) pH 8.0 and
washed six to seven times with PBS, pH 8.0. Cells were per-
meabilized with 0.5% Triton X-100 on ice for 5 min followed
by three PBS washes, blocked with blocking buffer (PBS,
3% BSA, 5% FBS and 0.5% Triton X-100) for 2 h at room
temperature or overnight at 4◦C. Following three additional
washes with PBS, cells were incubated with primary anti-
body overnight in PBS, 3% BSA and 0.5% Triton X-100.
Cells were washed five to six times with PBS and then in-
cubated with Atto488-conjugated secondary antibody. Af-
ter 2–3 h incubation, cells were washed six to seven times
with PBS and fixed with 1% PFA for 30 min. Following
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another five to six washes, coverslips were mounted onto
a slide with mounting medium (0.1% p-phenylenediamine
and 75% glycerol in PBS at pH 7.5–8.0) for FLIM or in Pro-
long Diamond for STED nanoscopy.
FLIM images were captured using a Leica SP5 II confo-
cal microscope with internal FLIM detector or a Leica SP8
FALCON. Atto488 was excited at 900 nm with titanium–
sapphire pumped laser (Mai Tai BB, Spectral Physics) with
710–920 nm tunability and 70 femtosecond pulse width. A
Becker & Hickl SPC830 data and image acquisition card
was used for time-correlated single photon counting (TC-
SPC); electrical time resolution was 8 picoseconds with a
pixel resolution of 256 × 256. Data processing and analy-
sis were performed using a B&H SPC FLIM analysis soft-
ware. The fluorescence decays were fitted to a single expo-
nential decay model. STED images were captured with a Le-
ica TCS SP8 STED 3× microscope capable of continuous-
wave Stimulated Emission Depletion (cwSTED) and gated
STED imaging, equipped with a 405 nm diode laser and a
tuneable super-continuum White Light Laser (WLL, 470–
670 nm) for excitation, as well as a 592, 660 and 775 nm
continuous wave depletion laser. An oil immersion objec-
tive (100×, NA 1.4) with optimal color correction was used
for imaging fixed samples at ∼23◦C embedded in refractive
index-matched media. Raw data acquired using the Leica
LAS X software were imported into the integrated Huygens
deconvolution software and processed.
ChIP-seq analysis and quality control
ChIP sequencing was performed in the Advanced Tech-
nology Genomics Core (ATGC) Facility at MD Ander-
son Cancer Center. Briefly, Illumina compatible indexed
libraries were prepared from 10–20 ng of Diagenode
Biorupter Pico sheared ChIP DNA using the KAPA Hy-
per Library Preparation Kit (KAPA Biosystems, Inc.). Li-
braries were amplified by 15 cycles of PCR, then assessed
for size distribution using the 4200 TapeStation High Sensi-
tivity D1000 ScreenTape (Agilent Technologies) and quan-
tified using the Qubit dsDNA HS Assay Kit (Thermo
Fisher.). Equimolar quantities of the indexed libraries were
multiplexed, nine libraries per pool. The pool was quanti-
fied by qPCR using the KAPA Library Quantification Kit
(KAPA Biosystems) then sequenced in one lane of the Il-
lumina HiSeq4000 sequencer using the 76 nt paired-end
run format. Triplicate samples were subjected to NGS for
AcNEIL1, Input and IgG controls. Fastq files were pre-
processed with the Trim Galore wrapper (trim galore –
fastqc –length 20 –paired run1, run2) for adapter trim-
ming (cutadapt) and reads quality control (FastQC). On
average, 1.9 ± 1.6% (mean ± SD) sequence pairs were
discarded because their length was below the threshold
and 37 345 085 ± 2 279 420 (values are given as mean
± SD unless otherwise specified) reads passed the filters.
Trimmed reads were mapped to both GRCh37/hg19 and
GRCh38/hg38 human genome assemblies with Bowtie2 us-
ing the -q –very-sensitive parameter. The overall alignment
rate was ∼1–2% higher for the hg38 than for the hg19
assembly. The alignment rate for IgG, 47.0 ± 6.0%, was
low compared to Input (98.4 ± 0.1%) and AcNEIL1 (98.0
± 0.9%). Thus, Input was used as control. Sorted bam
files and bam indices were obtained with samtools. Sorted
bam files were processed with ‘bedtools intersect’ to fil-
ter out a blacklist (file wgEncodeDacMapabilityConsensu-
sExcludable.bed.gz from (http://hgdownload.cse.ucsc.edu/
goldenpath/hg19/encodeDCC/wgEncodeMapability/ lifted
to hg38 coordinates for the hg38 mapping) of genomic re-
gions identified by the ENCODE consortium as yielding ar-
tifactually high signals. The utilities ‘macs2 filterdup’ and
‘macs2 predictd’ were then used to remove duplicates and
to extract fragment length to build a shifting model for
peak detection. Narrow peaks were called with ‘macs2 call-
peak’ using both a Poisson-distributed shifting model or a
‘noModel’ process with the fragment length obtained from
the ‘predictd’ parameter. The average number of peaks ob-
tained from the two methods was similar (49 608 ± 10 741
for noModel and 49 955 ± 10 169 for model for hg38; p
= NS). Therefore, we chose the peak collection from the
model for subsequent analyses. ChIPQC was used to assess
the quality of called peaks.
ChIP-seq downstream analyses
We used ChIPpeakAnno with the
TxDb.Hsapiens.UCSC.hg38.knownGene library to
annotate the peaks to genomic features using a proximal
promoter cutoff of 2 kb (from −2 kb to TSS) and an ‘imme-
diate downstream’ region cutoff of 1 kb (from TSS to 1 kb).
The percentage values obtained were normalized to the
number of bases comprising each genomic feature by run-
ning the python script extract transcript regions.py (https:
//github.com/stephenfloor/extract-transcript-regions) on
the UCSC knownGenes.txt file (http://hgdownload.cse.
ucsc.edu/goldenpath/hg38/database/). The number of
bases comprising promoters was obtained from the UCSC
refGene.txt file and a custom C++ script that provided
a list of nonredundant genomic coordinates. The total
number of bases covering genomic features were 63 159
536 for promoters, 32 933 397 for immediate downstream,
11 328 275 for 5′ UTRs, 46 852 188 for 3′ UTRs, 146 342
265 for exons, 1 642 804 337 for introns and 1 235 963 694
for intergenic regions.
We used two methods to map reads near TSSs. In the
first, we used seqMiner. Specifically, we loaded the sum-
mit coordinates of the first AcNEIL1 replicate (A1.1) along
with its bam file, set a seed value to 15 642 605, selected the
hg38 refSeq file as reference, chose the four most prominent
peak clusters (Figure 1B) and used the annotation file to
plot the number of peaks relative to ±20 kb of TSSs in in-
tervals of 250 bp. In the second method, we used an in-house
script to provide a bp-resolution map near TSSs. To this
end, we extended the summits’ coordinates by ±100 posi-
tions and then integrated these genomic coordinates within
±5 kb of TSS (from file refGene.txt) for all three replicates.
This was performed either without any filtering or by select-
ing only non-redundant coordinates from the reads. In cases
where there were common TSSs for multiple gene names
(like FAM138A, C, F), only one TSS instance was selected.
We used ChIPpeakAnno to find peaks in common (PICs)
among the three AcNEIL1 replicates and the genes contain-
ing these peaks. The P-values associated with the probabil-
ity of any two peak clusters between two replicates over-
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Figure 1. AcNEIL1 is predominantly localized in the nucleus. (A) 3D super-resolution STED nanoscopy of HCT116 cells comparing localization between
AcNEIL1 (top; green) and total NEIL1 (TtNEIL1) (bottom; green) with H3K27Ac (magenta) and DNA (blue); scale bar, 10 m. (B) Confocal microscopy
images of HCT116 cells stained with DAPI for nuclear DNA (blue), anti-AcNEIL1 specific antibody (green) and F-actin for cytoplasmic cytoskeleton
(yellow), and merged images, showing the efficient knockdown of NEIL1 by siRNA; scale bar, 10 m. (C) Immunoblotting (IB) of AcNEIL1 and total
NEIL1 after siRNA treatment in HCT116 cells. (D) Confocal microscopy and with fluorescence lifetime measurements and values displayed as false color
lifetime images mapped with pixel-by-pixel corresponding lifetime values (histograms). Fluorescence lifetime imaging microscopy (FLIM) was used to
measure the lifetime of Atto488-labeled AcNEIl1 as donor. FRET between Atto488-labeled AcNEIL1 and SiR-stained DNA in the presence of H3K27Ac
(ii) or total H3 (iii). Reference lifetime with donor alone (i) and donor without the acceptor (SiR Hoechst) but with Atto594 (iv). Control for FRET
between Atto488 and SiR Hoechst without Atto594-H3 (v). (vi) Control measuring the reference lifetime of APE1. (E) Immunoblotting (IB) of NEIL1,
AcNEIL1 and histone H3 from the chromatin fractions of HCT116 cells. Histone H3 served as the loading control. (F) Co-immunoprecipitation (Co-
IP) blots probing the association between AcNEIL1 and RNA Pol II, H4K16Ac, H3K27Ac, MeCP2 or H3K9me2 in IP complexes from HCT116 cells.
The detection of NEIL1 in AcNEIL1-pulled down fractions is expected since anti-NEIL1 antibody recognizes both forms. (G) Co-IP blots showing total
NEIL1 and AcNEIL1 in H3K27Ac-containing IP complexes in HCT116 cells.
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lapping were obtained by both omitting the parameter ‘to-
talTest’, in which case the estimated total number of bind-
ing sites was ∼113 900 and by specifying totalTest and then
varying the estimated total number of AcNEIL1 binding
sites.
Gene set enrichment analyses (GSEA) were per-
formed with DAVID (https://david.ncifcrf.gov/) and
IPA (https://www.qiagenbioinformatics.com/products/
ingenuity-pathway-analysis/) for genes that contained PICs
within 1, 2, 4, 6, 8, 10 kb of their TSSs (PIC genes) and,
for IPA, five additional control gene sets, each containing
1000 random genes. P-values for DAVID’s analyses were
corrected for multiple testing employing Benjamini’s
correction. Pathway analyses were from IPA.
External ChIP-seq data and analyses
The ChIP-seq data for modified histones (H3K27me3,
H3K36me3, H3K9m3 and Input control in HCT116
cells were obtained from http://hgdownload.cse.ucsc.edu/
goldenPath/hg19/encodeDCC/wgEncodeSydhHistone/
and consisted of the bigWig files. The annotation file
for the TSSs coordinates was gencode.v17.annotation.gtf
from ftp://ftp.sanger.ac.uk/pub/gencode/release 17/. For
XRCC1, we downloaded the original fastq file from
the GEO (https://www.ncbi.nlm.nih.gov/geo/) reposi-
tory (GSE95302, file SRR5282040) and processed it
according to the pipeline we used here. For Pol , we
obtained the bedGraph file from GEO, accession number
GSM2137770 and converted it to the bigWig format using
the bedGraphToBigWig utility from UCSC. This file con-
tained fewer reads than expected. The file for OGG1 was
GSM2357433 CP-Sample Flag-OGG1-Con-2.tdf from the
GEO record GSM2357433; the file was first converted to
a bedGraph format using the ‘igvtools tdftobedgraph’and
then to bigWig. All these ChIP-seq data were derived from
the MCF7 breast cancer cell line. When needed, files were
converted to the appropriate assembly using ‘bwtool lift’
(29). For mapping the ChIP-seq peaks to TSSs, we used
the ‘bwtool agg’ utility on the bigWig files and the hg19
assembly.
The H3K27ac and H3K9me3 ChIP-seq files used to
map the peaks overlapping with AcNEIL1 genome-
wide were ENCFF450AGJ and ENCFF077NZX,
respectively, mapped to the hg38 assembly from
https://www.encodeproject.org/reference-epigenomes/
ENCSR361KMF/, which corresponded to the narrow-
peaks replicates 1 and 2 obtained in the HCT116 cancer cell
line in bed format. The intersection with AcNEIL1 peaks
was performed by extending the center-peak positions by
100 bases on either side and retrieving the identical base
positions from both input files.
Expression of genes with PICs
We used TCGA-Assembler to download gene-normalized
RNA-seq expression data from TCGA available as
rsem-transformed data (.rsem.genes.normalized results
files). Genes were separated into AcNEIL1-negative and
AcNEIL1-positive according to whether or not they
contained PICs, and log2(normalized rsem + 1) values
were computed in both groups for all aggregated tumor
types and for each individual tumor type for PIC genes.
RNA-seq data for normal tissues were from (30). The
resulting P-values (Welch’s t-tests) were then used to build
a 2D Euclidean hierarchical-clustering heat map with the
R libraries ‘gplots’ and ‘RColorBrewer’. A similar heat
map with the same color-range in P-values was used to
aggregate the gene expression values for the five sets of
control genes relative to all other genes. Expression for
genes with PICs within 1 kb of TSS and for CBX8 was also
compared between TCGA tumors and matched controls
for those tumor types in which at least 10 control samples
were available (15 total). For the hierarchical clustering of
the RNA-seq data in normal tissues, AcNEIL1-positive
and AcNEIL1-negative genes were highlighted as sepa-
rate clusters on the y-axis. Hox gene expression data in
normal tissues were obtained from the GTEx Portal at
https://gtexportal.org/home/.
Survival analyses
For the Hox gene-related analyses, we first used the TCGA
RNA-seq gene expression data and clinical information to
conduct a comprehensive analysis of patient survival in all
33 available TCGA tumor types. To this end we divided pa-
tients with each tumor type into two groups: group 1, with
expression of gene x above the mean; and group 2, with
expression of gene x below or at the mean value. We then
used groups 1 and 2 to compute the Kaplan–Meier survival
curves and hazard ratios from the Cox proportional hazards
regression model using the R libraries ‘dplyr‘, ‘survival’,
‘survminer’ and the function ‘coxph’. P-values were from
log rank tests. For the gene correlation expression analyses
(GCEA), accurate P-values were obtained through the c++
boost F- and t-distribution functions (https://www.boost.
org), which enable the computation of values approach-
ing the numeric limit of 2.2e-306. Tumor abbreviations
are as follows. ACC, adrenocortical carcinoma; BLCA,
bladder urothelial carcinoma; BRCA, breast invasive car-
cinoma; CESC, cervical squamous cell carcinoma and en-
docervical adenocarcinoma; CHOL, cholangiocarcinoma;
COAD, colon adenocarcinoma; DLBC, lymphoid neo-
plasm diffuse large B-cell lymphoma; ESCA, esophageal
carcinoma; GBM, glioblastoma multiforme; HNSC, head
and neck squamous cell carcinoma; KICH, kidney chromo-
phobe; KIRC, kidney renal clear cell carcinoma; KIRP, kid-
ney renal papillary cell carcinoma; LAML, acute myeloid
leukemia; LGG, brain lower grade glioma; LIHC, liver
hepatocellular carcinoma; LUAD, lung adenocarcinoma;
LUSC, lung squamous cell carcinoma; MESO, mesothe-
lioma; OV, ovarian serous cystadenocarcinoma; PAAD,
pancreatic adenocarcinoma; PCPG, pheochromocytoma
and paraganglioma; PRAD, prostate adenocarcinoma;
READ, rectum adenocarcinoma; SARC, sarcoma; SKCM,
skin cutaneous melanoma; STAD, stomach adenocarci-
noma; TGCT, testicular germ cell tumors, THCA, thyroid
carcinoma; THYM, thymoma, UCEC, uterine corpus en-
dometrial carcinoma; UCS, uterine carcinosarcoma; UVM,
uveal melanoma. Somatic mutations in cancer were ob-
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tained from the Catalogue Of Somatic Mutations In Can-
cer (COSMIC, https://cancer.sanger.ac.uk/cosmic/), release
v91, 7 April 2020, file CosmicGenomeScreensMutantEx-
port.tsv.gz.
UCSC track visualization
To visualize the AcNEIL1 ChIP-seq data on the UCSC
browser, we used macs2 with the ‘bdgcmp’ option to gen-
erate fold enrichment (FE) and logLR peak enrichment
files in bedGraph format, which were then transformed
into BigWig format with the bedtools ‘slop’ option, fol-
lowed by sorting with bedClip and the UCSC utility bed-
GraphToBigWig. For correlations involving ChIP signals,
we used the data from the FE bedGraph files and inte-
grated the signals at each bp over 1 MB intervals. Inter-
vals at the end of chromosomes or over sequence gaps
containing <1 MB intervals were discarded. P-values for
the correlations between ChIP-signals and transcription or
gene density were derived from Welch’s t-tests using custom
c++ scripts.
Mutation data
A dataset of 25 472 007 SBSs in cancer genomes was ob-
tained from COSMIC (https://cancer.sanger.ac.uk/cosmic/
download) release v89 (19 May 2019) files CosmicGenome-
ScreensMutantExport.tsv and CosmicNCV.tsv, comprising
coding and noncoding variants, respectively. The dataset
was used after 2 763 747 (10.8%) duplicate entries were
filtered out. The list of SNPs (single nucleotide polymor-
phisms) occurring in the general population was obtained
from file snp151.txt (UCSC), which contained 683 635 300
entries. The file was filtered first by selecting field ‘genomic
single’ and excluding fields ‘SingleClassTriAllelic’ and ‘Sin-
gleClassQuadAllelic’, which left 555 714 904 entries. The file
was further filtered by selecting the data from the SweGen
study, which yielded a total of 34 956 631 SNPs present in
the Swedish population (31). Data from the Human Gene
Mutation Database (HGMD Professional, version 2017.3;
(32)) were downloaded and only variants for which genomic
coordinates and TSS information provided by HGMD were
available were used for the analysis (10 377 variants). All
HGMD variant classes were included (i.e. DM, DM?, FP,
DP and DFP; see Supplementary Table S3 for definitions).
Intrinsic protein disorder predictions
The Neil1 protein sequences for Homo sapiens (Q96FI4),
Mus musculus (Q8K4Q6), Rattus norvegicus (Q4KLM0),
Danio rerio (Q6TGW9), Bos taurus (F1MC42), Gallus
gallus (F1NLM0), Ovis aries (W5NWT2), Gorilla gorilla
(G3RFS6), Xenopus tropicalis (B1H3L2), Crassostrea gi-
gas (K1R5G2), Xenopus laevis (Q6GLL8), Capitella teleta
(R7VAR0) and Takifugu rubripes (H2UBV7) and their
phylogenetic tree were obtained from UniProtKB at http:
//www.uniprot.org/uniprot/. Protein disorder predictions
were evaluated using the online GeneSilico MetaDisorder
Service at http://genesilico.pl/metadisorder/. The results se-
lected for plotting were those obtained with MetaDisor-
derMD2, a method based on 13 disorder predictors.
Assembly of Alvinella pompejana genome and identification
of Neil1 gene
To identify the Neil1 gene in the extreme thermophile
Alvinella pompejana, we assembled the genome of this
annelid from ∼43 gigabases (Gb) of short WGS reads
from samples collected from hydrothermal vent sites (9◦N,
50/104◦W17) during a past expedition (33). For contig
and scaffold assembly, we used SOAPdenovo (http://soap.
genomics.org.cn/soapdenovo.html) with k-mer settings of
23–93 in steps of 10. Other variable settings were 100 and
151 for maximum read length, 436 for average insert, 100
and 143 for read length cutoff and 32 for map length, re-
spectively. The best setting combination (k-mer 63, max
read length 100 and read length cutoff 143) yielded a contig
N50 of 3657 bp and a scaffold N50 of 22.13 kb. Next we
performed a genome-wide ab-initio prediction of genes us-
ing Augustus (http://bioinf.uni-greifswald.de/augustus/) af-
ter training the software on an A. pompejana EST library
merged from three laboratory sources (34). The combined
genome and EST libraries yielded a proteome comprising
>60 000 full-length proteins and partial peptides. A. pom-
pejana Neil1 was identified in this annelid’s proteome from
a blast search (e-value, ∼5 × 10−105) using human NEIL1 as
bait, which returned both full-length genomic and an EST
entry from (34).
Human NEIL1 homologues
Protein sequence data for 241 human NEIL1 homologues
were obtained with blastp (https://blast.ncbi.nlm.gov/Blast.
cgi?PAGE=Proteins) and aligned using Clustal Omega
(https://www.ebi.ac.uk/Tools/msa/clustalo/). In Saurop-
sida, protein alignments with human NEIL1 were manually
adjusted to account for a 4-aa insertion in Passeriformes
after S295. In Supplementary Figure S6C, the lengths of
lines do not imply divergence times.
Statistical information
Pairwise Student’s t-tests and Welch’s tests used two-
tailed distributions. P-values for DAVID’s gene enrichment
were corrected for multiple testing using the Benjamini–
Hochberg procedure.
RESULTS
We recently showed that p300 acetylates NEIL1 (herein re-
ferred to as AcNEIL1) at residues Lys296, Lys297 and Lys298,
which serves to increase DG activity and stabilize the en-
zyme on chromatin-bound complexes (17). We reasoned
that defining the extent to which the cell uses this PTM to
achieve genome-wide repair could provide insights into effi-
cient damage recognition and the contribution of AcNEIL1
to modulating mutational loads in the context of both evo-
lution and cancer genomes.
AcNEIL1 localization
Stimulated emission depletion (STED) nanoscopy pro-
vides super-resolution images through the selective deac-
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tivation of fluorophores. STED of human colorectal ade-
nocarcinoma HCT116 cells labeled with anti-AcNEIL1 or
anti-total-NEIL1 antibodies showed strong AcNEIL1 nu-
clear localization, as opposed to diffuse staining in nu-
clei and cytoplasm for non-acetylated NEIL1. AcNEIL1
staining superimposed upon histone H3 acetylated at ly-
sine 27 (H3K27Ac), a marker of active enhancers and
transcriptionally-active chromatin (Figure 1A). We there-
fore used confocal microscopy to examine AcNEIL1 local-
ization in several human-derived cell lines with various de-
grees of ploidy, from hypodiploid (Skov3) to near-diploid
(HCT116, Jurkat), aneuploid (HeLa, MDAMB231), near-
triploid (PC3, K562) and hypertriploid (U2OS); in all cases,
AcNEIL1 displayed preferential localization to the nuclei
(Supplementary Figure S1A).
We also assessed AcNEIL1 localization in a chronic
myelogenous leukemia cell line (HAP1), which has a
distinctive near-haploid genotype; in these cells, we de-
tected AcNEIL1 throughout the cell bodies (Supplemen-
tary Figure S1B). We validated the specificity of the anti-
AcNEIL1 antibody using siRNA-mediated NEIL1 knock-
down, which abolished both cellular NEIL1 staining (Fig-
ure 1B and Supplementary Figure S1C) and protein lev-
els (Figure 1C and Supplementary Figure S1D). Thus, ex-
cept for the near-haploid leukemia HAP1 cell line, the data
shows AcNEIL1 staining appears to be confined to nuclei
in cancer cells.
Next, we used fluorescence lifetime imaging microscopy
(FLIM) to detect fluorescence resonance energy transfer
(FRET) between donor, Atto488-labeled AcNEIL1 and
acceptor, SiR-stained DNA. FRET occurs if donor and
acceptor are within 10 nm of each other, which causes
a reduction in donor fluorescence lifetime. The Atto488-
labeled AcNEIL1 fluorescence lifetime centered around
2.35 nanoseconds (ns) (Figure 1Di), but left-shifted to 2.2
ns in the presence of labeled DNA (Figure 1Dii). This sig-
nificant 150 picoseconds (ps) reduction in fluorescence life-
time indicates that AcNEIL1 localized to within 10 nm
of chromosomal DNA. Cells were also counter stained
with H3K27Ac and histone H3 with an Atto594-coupled
secondary antibody (Figure 1Dii and iii). Despite histone
proteins being wrapped around DNA, no FRET between
Atto594-histone H3 and SiR-Hoechst was observed, per-
haps reflecting a greater distance of the histone tails from
DNA than the one observed for AcNEIL1. The specific
nature of FRET between Atto488-labeled AcNEIL1 and
SiR-Hoechst was confirmed with cells lacking SiR-Hoechst
(Figure 1Div versus v).
H3K27Ac (Figure 1Dii) colocalized with AcNEIL1 on
condensed chromosomes to a greater extent than total hi-
stone H3 (Figure 1Diii) and, likewise, AcNEIL1 yielded
stronger fluorescent signal than total NEIL1 in nuclei
(Supplementary Figure S2A, green trace). We did not ob-
serve FRET between SiR-DNA and Atto488-labeled total
apurinic/apyrimidinic (AP) endonuclease 1 (APE1), a com-
ponent of the BER pathway that is also stabilized on chro-
matin upon acetylation (35). We also co-stained AcNEIL1
with the heterochromatin marker HeK9me3 in HCT116
cells and used FLIM to determine their distance. Unlike
with AcNEIL1 and H3K27ac, we found only a small por-
tion of co-localization between AcNEIL1 and HeK9me3
(Supplementary Figure S2B). Likewise, with FLIM we did
not see a shortening of the average fluorescence lifetime for
the AcNEIL1/HeK9me3 pair relative to AcNEIL1 alone,
suggesting negligible interaction between them (Supple-
mentary Figure S2B).
We therefore performed western blotting to further as-
sess the comparative recruitment of total NEIL1 versus Ac-
NEIL1 at the chromatin in HCT116 cells. Immunoblotting
showed that 50 M of the HAT inhibitor garcinol reduced
the level of AcNEIL1 compared to 10 M. Hence the level
of total NEIL1 was also proportionally decreased in the
chromatin fractions compared to that of mock treatment.
Likewise, treating the cells with the HDAC inhibitor NAM
at varying doses increased the chromatin contents of both
total NEIL1 and AcNEIL1 compared to the mock treat-
ment (Figure 1E and Supplementary Figure S2C). These re-
sults, which support and extend our previous findings (17),
suggest that recruitment of NEIL1 on the chromatin de-
pends on its level of acetylation.
Co-immunoprecipitation (co-IP) experiments, in which
either AcNEIL1 (Figure 1F) or H3K27Ac (Figure 1G) were
pulled-down from cellular fractions confirmed close asso-
ciation between AcNEIL1 and H3K27Ac. In addition, hi-
stone H4 acetylated on lysine 16 (H4K16Ac) and RNA
polymerase II were also associated with AcNEIL1, support-
ing the colocalization of AcNEIL1 within euchromatin do-
mains. By contrast, no coprecipitation was observed for ei-
ther methyl CpG binding protein 2 (MECP2) or histone H3
methylated on lysine 9 (H3K9me), both of which are mark-
ers of heterochromatin. We conclude that AcNEIL1 is re-
cruited to nuclear foci in near-diploid and aneuploid cancer
cells, where it forms chromosomal complexes within regions
of transcriptionally active chromatin.
AcNEIL1 punctuates TSSs of genes involved in cancer and
development
To obtain a genome-wide map of AcNEIL1 localization,
we employed chromatin immunoprecipitation-sequencing
(ChIP-seq) assays. From three independent experiments in
HCT116 cells, anti-AcNEIL1 antibody achieved an ∼3-
fold enrichment of reads within peaks (6.3 ± 1.1%; mean
± SD) relative to input controls (2.0 ± 0.1%, P = 0.002
from Student’s t-test), with few reads in false-positive hit
regions (blacklist regions, Supplementary Figure S3A and
Table S1). A clustering heatmap on the co-occurrence of
peaks also showed a net distinction between the AcNEIL1
samples and input controls (Supplementary Figure S3B),
increasing our confidence in the interpretation of down-
stream analyses. Mapping of reads within genomic features,
using either narrow- or broad-peak methods, revealed the
highest AcNEIL1 densities within the coding portions of
genes and their promoters (∼0.1% peaks/Mb), followed by
introns (∼0.038% peaks/Mb) and lastly intergenic regions
(∼0.01% peaks/Mb) (Figure 2A). Peak enrichment rela-
tive to controls varied along the PCR-amplified fragments
(Figure 2B); however, AcNEIL1 binding occurred most fre-
quently within 1 kb downstream of TSSs (Figure 2C and
Supplementary Figure S3C).
Given our confidence in the specific PCR amplification of
chromatin-bound AcNEIL1, we examined peaks that over-
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Figure 2. AcNEIL1 punctuates TSSs of genes associated with poor survival in cancer. (A) Annotation of AcNEIL1 peaks associated with genomic features
for the 3 replicates. Pairwise P-values from Student’s t-test between TSS to 1kb downstream (ImmDown) and other features. Results represent the mean ±
SD. ** 0.001; *** < 0.001; n = 3. (B) Clusters of peaks enriched for AcNEIL1 (A1.1) relative to Input (I1.1) for the first replicate extended ±200 bp from the
summits as obtained from seqMiner. (C) Annotation of peaks from (B) to TSSs using the seqMiner annotation file to display the number of peaks relative
to ±20 kb of TSSs in intervals of 250 bp. (D) Venn diagram of PICs for the three AcNEIL1 replicates (A1.1, A1.2, A1.3) obtained with ChIPpeakAnno.
(E) Main DAVID-enriched gene ontology (GO) categories for genes containing AcNEIL1 PICs obtained with ChIPpeakAnno. Gene sets, distance of PICs
from TSSs. IPRO, INTERPRO; SM, SMART; USF, UP SEQ FEATURE. (F) Heat map of log rank P-values from Kaplan–Meier survival curves where
expression of a Hox gene either above (blue) or below (pink) the mean value was a risk factor in cancer patients. (G) Bar plot of significantly enriched GO
terms containing one or more Hox genes from GSEA using all genes associated with poor survival (log rank P-value < 0.001) in LGG and KIRC when
expressed above mean levels.
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lapped among the three replicates, which we termed ‘peaks
in common’ (PICs) and which represented high-confidence
AcNEIL1 binding sites. A total of 13 647 PICs (Figure
2D) were identified through the narrow-peak method (21
173 PICs were identified through the broad-peak method),
which we assessed for statistical significance. The P-value,
obtained from the hypergeometric test (using an estimate
of 113 900 for the total number of binding sites, the amount
of coding sequence and regulatory DNA and average peak
width), was highly significant (Supplementary Figure S3D).
The functional annotation of genes containing PICs lo-
cated from 1 to 10 kb from TSSs revealed the strong
overrepresentation of homeodomain-containing Hox genes
(Figure 2E), both for the narrow- and broad-peak methods.
In addition, Ingenuity Pathway Analysis (IPA) identified a
variety of ‘terms’ associated with genes implicated in cancer,
whose P-values vastly exceeded those obtained from ran-
domly chosen gene sets (Supplementary Figure S4A). IPA
also revealed the enrichment of genes related to ‘gene ex-
pression’ and ‘cell movement’ (Supplementary Figure S4B).
For cancer- and development-related genes, causal network
analysis identified CBX8 (for cancer, Supplementary Figure
S4C) and Hox genes (for development, Supplementary Fig-
ure S4D) as target nodes, suggesting that AcNEIL1 prefer-
entially targets the TSSs of genes that are relevant to cancer
and organ development.
High expression of PICs-containing Hox genes is associated
with poor survival in cancer
To test the possible relevance of AcNEIL1-bound Hox
genes to cancer, we performed a survey across the 33 TCGA
tumor types to assess association between differential ex-
pression of Hox genes and patient survival by using the
Kaplan–Meier estimator and Cox-derived hazard ratios. Of
the 39 Hox genes, 12 were associated with poor progno-
sis in 17 types of tumor for a total of 43 cases; 40 cases in
which high expression (above the mean in tumor samples)
was a risk factor, and 3 in which low expression (below the
mean in tumor samples) was a risk factor (Figure 2F). Of
the 12 Hox genes, 7 (58%) contained AcNEIL1 PICs out of
the 9 with PICs, more than expected by chance alone (P =
0.002, Fisher exact test). We therefore extended the survival
analysis to all genes in all TCGA tumor types to perform
a comprehensive gene set enrichment analysis (GSEA) and
extracted gene ontology (GO) terms enriched in Hox genes.
At a log rank P-value < 0.001 from the Kaplan–Meier esti-
mator, for the association between high expression and poor
survival, Hox genes were enriched in eight GO terms in low
grade glioma (LGG), which were related to embryonic pat-
tern specification, cell-matrix adhesion and transcription
(Figure 2G). Two Hox-containing GO terms were also ob-
served in kidney renal clear cell carcinoma (KIRC), both
of which were related to transcriptional regulation (Figure
2G).
The association of Hox overexpression with poor sur-
vival raised the question whether other genes might have
been responsible for the outome, rather than Hox. There-
fore, we performed a comprehensive GSEA on all ∼20
000 genes in all 33 TCGA tumor types; in both LGG and
KIRC, poor survival was dominated by the overexpression
of genes related to the activation of cell cycle and mito-
sis (FDR values down to 1 × 10−15 in both cases) and,
in LGG, to a strong activation of the innate immune re-
sponse (FDR of 4.7 × 10−21). GO terms linked to mitotic
genes also led the association with poor survival in other tu-
mors, including adrenocortical carcinoma (ACC), mesothe-
lioma (MESO), lung adenocarcinoma (LUAD), pancreatic
adenocarcinoma (PAAD), kidney renal papillary cell car-
cinoma (KIRP) and breast invasive carcinoma (BRCA).
Thus, cell hyperproliferation was the most common prog-
nostic marker for poor survival in cancer. Of the tumor
types in which a Hox overexpression-survival relationship
was noted, ∼10 – 25 Hox genes were expected to be ex-
pressed, in some cases at high levels, in 8/12 of their pu-
tative adult tissues of origin (Supplementary Figure S5A).
Therefore, we sought to clarify the relationship between cell
hyperproliferation and Hox overexpression by selecting the
top genes that were enriched in GO terms in at least 6 tu-
mor types in the comprehensive survival analysis, and which
would also be overexpressed in all tumor types when com-
pared to matched controls (15 tumor types with matched
controls were available). Thirty genes fulfilled our criteria,
including two prominent transcription factors (TFs) with
critical roles in cell prolideration, FOXM1 and MYBL2.
This enabled us to conduct a gene coexpression analysis
(GCEA) to assess the linkage between Hox overexpression
and the activation of cell proliferation in LGG.
At a Bonferroni-corrected -log10 P-value threshold
of 5.40 (regression coefficient r = ∼|0.200|), ∼80% of
all Hox genes displayed significant co-expression with
MYBL2 and FOXM1. Yet, only about half of the PICs-
containing Hox genes did; moreover, 7/9 PICs-containing
Hox genes showed coexpression levels below the median
value, with HOXB1, HOXC12 and HOXD12 being ex-
pressed in <100/532 LGG cases (Supplementary Figures
S5A and B). A list of all genes ranked by the strength of co-
expression with FOXM1 and MYBL2 indicated -log10 P-
values down to ∼10−250 with r-values up to 0.94 for genes
such as HJURP and KIFC1, which play critical roles in mi-
tosis. The ranking order was biphasic, with an estimated
∼200 genes being prime proliferative targets or co-amplified
with MYBL2 and FOXM1, as assessed from initial slope ex-
trapolation (Supplementary Figure S5B, insets), and genes
with -log10 P-values below 18–20 likely representing weak,
indirect transactivation and possibly non-casual relation-
ships. In sum, analysis of the available data indicates that in-
dependently of other key drivers of cellular hyperprolifera-
tion, such as FOXM1 or MYBL2 (36), in LGG activation of
Hox gene expression, particularly for PICs-containing Hox
genes, leads to poor outcome.
Transcription spreads AcNEIL1 along gene bodies
Based on the co-IP results (Figure 1F and G), we antici-
pated that AcNEIL1 would localize to highly transcribed
genes; thus, the colocalization between PIC-containing
genes and the Hox family was surprising given that these
transcription factors exhibit broadly restricted expression
in adult tissues (37) (Supplementary Figure S5A). Indeed,
quantitative transcriptomic data from 32 types of adult
normal tissue (30) revealed that the 1148 PIC-containing
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genes with AcNEIL1 within 1kb of TSSs (A1 1kb) clus-
tered mostly with weakly transcribed genes (Supplementary
Figure S6A) and were expressed at lower levels than the re-
maining 19 196 genes (Figure 3A). The same pattern was
observed in cancer tissues, where A1 1kb-associated genes
were expressed at lower levels than the remainder of the
genes for all 33 types of tumor from TCGA (Figure 3B, up-
per row). Despite these commonalities, A1 1kb-associated
genes were expressed at higher levels in the tumor masses
than in matched normal tissues for 7/15 tumor types, par-
ticularly in liver hepatocellular carcinoma and non-small
cell lung carcinoma (Figure 3C); CBX8, in particular, was
upregulated in all tumor types except chromophobe renal
cell carcinoma (KICH, Supplementary Figure S6B).
Next, we analyzed the expression profiles of PIC-
containing genes when AcNEIL1 was located at increasing
distances from TSSs. Transcription levels increased, in both
TCGA (with the sole exception of acute myeloid leukemia)
and in normal tissues, often exceeding those of AcNEIL1-
negative genes (Figure 3B). This differential transcription
between AcNEIL1-positive and AcNEIL1-negative genes
was not due to sampling bias, as confirmed by a parallel
analysis of five sets of 1000 randomly chosen genes each,
which showed no differences in transcription levels between
the random genes and the AcNEIL1-negative genes for
162/165 cases, and weak P-values for the remaining three
cases (mesothelioma 0.03, testicular germ cell tumor 0.01
and uterine carcinosarcoma 0.04, Supplementary Figure
S6C).
We then analyzed PICs in more detail, expecting PICs
to contain the upper (strongest) end of P-values from the
list of all called peaks from the three replicates, since these
P-values would imply high-confidence AcNEIL1 map-
ping. Surprisingly, PIC analysis missed 1938/149 498 peaks
(1.3%) with the strongest P-values and the highest enrich-
ment ratios (>5.3, Supplementary Figure S6D). Indeed,
the percentage of peaks mapping just downstream of TSSs
were at their highest for both the most- and least-enriched
peaks (Figure 3D), and the genes containing these peaks
were expressed at low levels when located within 1 kb of
TSSs. These apparent anomalies imply that peak enrich-
ment per se is not a prime metric for AcNEIL1 binding.
Rather, high-confidence AcNEIL1 binding appears to orig-
inate from the overlap of adjacent genomic binding areas,
as deduced from the longer peak lengths near TSSs (Sup-
plementary Figure S6E) and the smooth decrease in peak
lengths that were observed when AcNEIL1 was found fur-
ther away from TSSs (Figure 3E). These composite data
show that AcNEIL1 binding to genomic DNA is fluid,
in accordance with its lack of sequence-binding specificity
and DNA-tracking properties. In sum, AcNEIL1 localizes
to the TSS region in weakly transcribed genes; however,
an increase in transcriptional activity may provide a larger
or more long-lived open chromatin environment to enable
wider genomic segments to be scanned by AcNEIL1.
Gene-dense and highly transcribed domains are enriched in
AcNEIL1
To further examine NEIL1 locailzation, we tested whether
AcNEIL1 mapping could be confirmed by quantitative as-
says. Therefore, we conducted AcNEIL1 ChIP at selected
loci followed by quantitative PCR amplification (ChIP
qPCR) (Supplementary Table S2) and compared the re-
sults using Chip-seq peaks visualized on the University of
California, Santa Cruz (UCSC) genome browser. At the
highly transcribed MYC locus, ChIP qPCR yielded a sig-
nal, ∼20% relative to the input, while ChIP-seq identified
several strong peaks over broad regions (Figure 4A, left).
By contrast, at the poorly transcribed MYL1 locus, the
ChIP qPCR signal was ∼10-fold lower than at MYC and
ChIP-seq displayed sparse peaks (Figure 4A, right). The
ChIP qPCR signals for both AcNEIL1 and H3K27Ac at
three high-transcription loci and three low-transcription
loci revealed preferential AcNEIL1 occupancy at high-
transcription loci (Figure 4B), confirming our observation
that AcNEIL1 maps throughout transcribed gene bodies.
We next explored whether AcNEIL1 is dislodged from
its placement at TSSs upon transcriptional activation.
The promoter for the retinoic acid (RA) receptor  gene
(RARB) contains an RA-responsive element (RARE)
which, when activated, stimulates gene expression and BER
activity in response to a transient surge in ROS (38); how-
ever, in HCT116 cells RARE is not inducible by RA
(39,40), and the RARB promoter is poorly occupied by Ac-
NEIL1 (Figure 4C). By contrast, in the embryonic cell line
HEK293, RARE is readily activated by RA (Figure 4D).
Prior to activation, the RARB promoter was fully occupied
by AcNEIL1 and full occupancy continued to be observed
30 min after RA activation, while transcription occurred at
background levels. After 2 h, when transcriptional activa-
tion was detectable, the amount of AcNEIL1 had decreased
by 5-fold (Figure 4E). Thus, this RA-inducible system pro-
vided proof-of-principle that AcNEIL1 found at TSSs is
poised for transcription-induced repair.
On a chromosome-wide scale, the AcNEIL1 land-
scape comprises densely populated ‘cities’ interspersed with
‘deserts’, and the sex chromosomes were generally found
to be devoid of cities (Figure 4F and Supplementary Fig-
ure S7). Close inspection of ChIP-seq peaks suggested that
AcNEIL1 acted as a marker for high-transcription areas
in closely spaced gene domains (Figure 4F); at the 1-Mb
scale, the AcNEIL1 integrated ChIP-signal (ICS) corre-
lated with both gene density (Figure 4G) and transcription
level (Figure 4H). The strength of the correlation between
AcNEIL1 and the transcription level was also strong for
the different TCGA tumor types, with the sole exception
of acute myeloid leukemia (Supplementary Figure S8A),
where AcNEIL1 PIC-containing genes failed to display
TSS distance-dependent increases in transcription (Figure
3B).
To assess the extent to which AcNEIL1 might be part
of BERosomes preloaded onto chromatin, we conducted
a comparison between AcNEIL1 and available ChIP-seq
data for other BER components. Despite differences in
methods used, the peak profiles for AcNEIL1, XRCC1 and
Pol  near TSSs were remarkably similar, with a ‘gully’ at
TSSs flanked by ridges (Figure 4I). By contrast, OGG1 dis-
played a prominent maximum at TSSs (Supplementary Fig-
ure S8B), as previously reported (41). The profiles for the
modified histone H3K27ac were also qualitatively similar
to that of AcNEIL1 close to TSSs (Supplementary Figure
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Figure 3. Transcription spreads AcNEIL1 along gene bodies. (A) Geometric box plot of aggregate transcript levels for genes with and without AcNEIL1
PICs within 1 kb of TSS in normal tissues. Dot, mean; bar, median; P-value from Wilcoxon test. (B) Left, 2D hierarchical clustering of P-values from
Wilcoxon tests for transcript levels for genes with and without AcNEIL1 PICs within 1, 2, 4, 6, 8, 10 kb of TSSs in 33 TCGA tumor types (black labels)
and in normal tissues (red label). Green, lower expression in genes with AcNEIL1 than in genes without AcNEIL1; red, higher expression in genes with
AcNEIL1 than in genes without AcNEIL1. Scale, -log P-values. Note that unsupervised clustering ordered the P-values according to AcNEIL1 distances
from TSSs (left label). Right, geometric box plots for transcript levels in 33 TCGA datasets for genes with AcNEIL1 at various distance from TSS; box
widths scaled to the squared root of the number of observations: 37 392 (1 kb), 51 153 (2 kb), 69 568 (4 kb), 81 778 (6 kb), 91 645 (8 kb) and 99 367
(10 kb). P-values from Welch’s t-tests. (C) Box plots of gene expression for genes with AcNEIL1 PICs within 1 kb of TSS in TCGA tumors and matched
controls. Only control datasets with >10 samples were assessed. P-values from Wilcoxon tests. (D) Bottom, percent genomic positions within the immediate
downstream 1 kb of TSS (ImmDown) for the three AcNEIL1 replicates at different fold enrichment values: 4.3 (≥4.2 and ≤4.31), 3.3 (≥3.26 and ≤3.31),
2.3 (≥2.25 and ≤2.48). Positions analyzed were from summits ±100 bases. The ensemble of genomic features included promoters (−2 kb to TSS), 5′-UTRs,
ImmDown, exons and 3′-UTRs. Top, box plots of gene expression in normal tissues for genes with and without AcNEIL1 containing peaks at various fold
enrichments (Peak enrichment) from the three replicates. P-values from Welch’s t-tests. (E) Length of AcNEIL1 PICs identified with ChIPpeakAnno as a
function of distance from TSSs; data show mean and SD; P-values from Welch’s t-tests.
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Figure 4. Gene-dense and highly transcribed domains are enriched in AcNEIL1. (A) ChIP-seq enriched peaks for the AcNEIL1 replicates visualized on the
UCSC genome browser in ln(logLR + 1) units (range = 0–3, top) with splicing isoforms (Genes) and direction of transcription (arrows); transcriptional
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S8B), but contrasted with the marks of more condensed
chromatin: H3K9me3, H3K36me3 and H3K27me3 (Sup-
plementary Figure S8C). On a genome-wide scale, the over-
lap of AcNEIL1 peaks with those of H3K27ac was 11-fold
greater than for those with H3K9me3 and 36-fold greater
than the overlap between H3K27ac and H3K9me3 (Sup-
plementary Figure S8D), in accordance with our IP, im-
munofluorescence and FLIM analyses. Visualization of the
ChIP-seq peaks on the UCSC genome browser for a por-
tion of chromosome 1 also indicated close correspondence
between the BER components AcNEIL1, XRCC1 and the
more limited data for Pol  (Supplementary Figure S8E).
Taken together, these data provide a foundation for the con-
cept that AcNEIL1 acts as a sentinel for surveilling DNA
damage in open chromatin in the context of active BERo-
some complexes.
AcNEIL1 occupancy correlates with low mutation rates
If AcNEIL1 were primarily responsible for detecting and
correcting DNA damage, we reasoned that mutational
loads ought to decrease with increasing AcNEIL1 occu-
pancy. We therefore analyzed ∼25.4 million SBSs specific
to tumor samples, including 5.6 million coding region muta-
tions and 19.8 million non-coding variants. When analyzing
20 1-Mb genomic bin pairs, where AcNEIL1 ICS was low
(<350 000) in one member of the pair but high (>950 000)
in the other member of the pair, and where each pair shared
near-equal transcription levels, AcNEIL1-high bins exhib-
ited significantly fewer SBSs than AcNEIL1-low bins (Sup-
plementary Figure S9A). When SBSs were decomposed into
the six contributing spectra (i.e. G>A plus C>T etc., sim-
plified to G>A), all types of substitution occurred less fre-
quently in AcNEIL1-high bins than in AcNEIL1-low bins,
with the exception of G>A transitions, whose numbers re-
mained unchanged (Supplementary Figure S9B).
To explore these observations further, we separately ad-
dressed the contributions of transcription and AcNEIL1
to mutagenesis, with the goal of capturing zeroth-order ki-
netic behaviors, where the rate, k, is derived from linear
equation slopes, such that k = [P]/[X]. In this case,
P was the number of SBSs per 1-Mb bins and X was ei-
ther the AcNEIL1 concentration or mRNA levels, as a
proxy for the amount of single-stranded DNA exposed to
damage or modification by enzymes, such as apolipopro-
tein B mRNA-editing enzyme, catalytic polypeptide-like
(APOBEC) (42,43). No AcNEIL1-low bins were associ-
ated with high transcription levels; therefore, we compiled
six sets of 10 1-Mb bins containing AcNEIL1-high regions
(>950 000 ICS), with varying levels of transcription. We
excluded the bin at chr17:7000000 associated with TP53,
which contained an abnormally high number of SBSs, 45
787/63 999 of which occurred solely at the TP53 locus. This
bin also displayed the highest level of transcription (350.6
units). A plot of SBSs versus transcription levels revealed a
positive and linear relationship (Figure 5A), consistent with
a zeroth-order kinetics model. A total of five to six muta-
tion spectra also revealed positive slopes, with G>A dis-
playing an ∼10-fold higher rate than those for G>C, G>T,
A>C and A>G, whereas A>T exhibited no changes (Fig-
ure 5B). Conversely, the plot for 351 1-Mb bins with vari-
able amounts of AcNEIL1 ICS but no transcription (<5
units) followed zeroth-order behavior but the rate was neg-
ative (Figure 5C). Importantly, G>A transitions remained
constant, whereas those for the other five types of substi-
tution decreased, particularly A>T transversions (Figure
5D).
On a genome-wide scale, the rates of G>A transitions
increased steadily (Figure 5E) whereas those for the other
five types of substitution displayed negative initial veloci-
ties, followed by near-constant SBS accumulations (Figure
5F and G), as expected. We conclude that transcription is an
intrinsically mutagenic process, and that chromatin-bound
AcNEIL1 is the active DG form of NElL1 in the context of
BERosomes, which is responsible for the repair of oxidative
DNA damage and the prevention of base-pair change accu-
mulations, particularly transversion mutations at A:T base
pairs.
Segmental patterns of DNA repair by AcNEIL1 are heritable
After establishing that the local variations in mutation rates
observed in cancer genomes coincide with segmental Ac-
NEIL1 occupancy, we next addressed whether similar pat-
terns exist for genetic variations between populations. We
selected SweGen, a database of single nucleotide polymor-
phisms (SNPs) in the Swedish population, which is compa-
rable in size (∼23 million SNPs) to the cancer dataset. No
qualitative differences were observed in the genome-wide
distribution of SNPs as a function of AcNEIL1 ICS com-
pared with those observed for cancer. Specifically, G>A
transitions displayed a linear dependence on AcNEIL1
(Figure 5H), whereas the remaining five mutational spec-
tra exhibited two distinct rates (Figure 5I and J), a higher
rate at low ICS and a lower rate at high ICS. No quali-
tative differences were observed among different types of
bins containing sparse AcNEIL1 ICS, which were associ-
ated with olfactory receptor (OR) genes (Figure 5F and I).
←−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−
profiling (RNA-seq) and histone H3 acetylated at Lys27 (H3K27Ac,) from ENCODE; AcNEIL1 ChIP qPCR quantitation (% relative to Input) at a
strongly (MYC, left) and weakly (MYL1, right) transcribed gene. (B) AcNEIL1 and H3K27Ac ChIP qPCR quantitation (from A). Results represent the
mean ± SEM; n = 4. P-values are from Welch’s t-tests for the aggregate data at high (orange, 14.1 ± 3.2 mean ± SD) versus low transcription (blue, 3.2
± 1.7 mean ± SD). (C–E) Modulation of promoter-specific AcNEIL1 levels during RA-induced transcriptional activation of RARB in HEK293 cells. (C)
As in A for the RARB gene in HCT116 cells showing the paucity of AcNEIL1 peaks at TSSs. (D) RARB expression by RT-PCR normalized to HPRT1
expression; mean ± SEM, n = 3. (E) AcNEIL1 ChIP qPCR for the −165 to +82 region containing RARE on the RARB promoter versus a non-specific
(ns) control region on chromosome 17 with no RARE after RA treatment; mean ±SEM, n = 3. (F) UCSC genome browser custom tracks for AcNEIL1
ICS peaks, as in A, for chromosome 1, showing all TSSs (maroon ticks) and gene density in TSS/Mb (top gray). (G) Plot of AcNEIL1 ICS (x-axis) for
A1.2 versus gene density. Each point represents the integration over 1 Mb of ICS with FE (fold enrichment) output and the number of annotated TSSs
over the same genomic region (y-axis). (H) As in G, the y-axis represents the RNA-seq fpkm data from averaged normal tissues from (22). (I) Profile of
aggregate Chip-seq read depth near TSSs in HCT116 cells for AcNEIL1, XRCC1 and Pol . Signals were normalized by the total amount of signal within
the −5–5 kb interval.
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Figure 5. AcNEIL1 occupancy correlates with low mutation rates. (A) Mutation loads in cancer genomes increase with transcription. Mutations were
computed for 6 different types of genomic region each containing 10 1-Mb bins with high AcNEIL1 ICS (∼1 million counts/bin) but increasing transcrip-
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Quantitatively, the frequency of incurring base changes at
low AcNEIL1 (<500 000 ICS) was greater in cancer than
in the germline, particularly for A>T and A>C transver-
sions (Supplementary Figure S9C). Plots of SBSs or SNPs
as a function of transcription level failed to distinguish two
rates of base substitution (Supplementary Figure S9D and
E), either on a linear or a logarithmic scale, since bins with
and without AcNEIL1 were no longer distinguished.
Using custom scripts (36,44), we searched for DNA mo-
tifs that can fold into stable G4 structures and detected
their enrichment at TSS-flanking regions (Supplementary
Figure S9F), where some are expected to be incorporated
into 5′-untranslated regions (UTRs). G4-DNA and its com-
plementary C-rich strand contain unpaired bases, which
are susceptible to DNA damage (45); AcNEIL1 colocal-
ization at TSSs is suggestive of protection at these vulnera-
ble sites. We surveyed the Human Gene Mutation Database
(HGMD) to assess the frequency of variants at G4 DNA
motifs in 5′-UTRs known to cause or predispose toward in-
herited disease. A total of 13 loci were identified (Supple-
mentary Table S3); however, two of them, located respec-
tively within the DNA repair genes RAD51 and XRCC1
with pivotal roles at the replication-repair interface (46,47),
may confer an increased burden of morbidity upon the hu-
man population by increasing genome instability and hence
susceptibility to cancer.
Evolutionary origin of the AcNEIL1 acetylation center
Given the key and prototypical role of AcNEIL1 in genome
repair, we examined the evolutionary conservation of Neil1
and its acetylation center in the two main lineages of bila-
teria (560–0 Ma), deuterostomes and protostomes. We in-
cluded the sequence of the polychaete worm A. pompejana,
an ancestral extremophile residing in deep-sea hydrother-
mal vents (48), which we obtained from partial genome as-
sembly from specimens collected during an expedition on
the East Pacific Rise (Supplementary Figure S10A). A to-
tal of 241/260 species comprising all deuterostomes (540–
0 Ma) and Lophotrochozoa (536–0 Ma), and part of the
Ecdysozoa clade displayed strong evolutionary conserva-
tion (blastp values between 7e−64 and 33−112), although no
significant hits were found in Nematoda and Hexapoda,
which include the model genomes of Caenorhabditis elegans
and Drosophila melanogaster (Figure 6A).
The AcNEIL1 acetyl acceptors, Lys296, Lys297 and
Lys298, are embedded within an intrinsically unstruc-
tured carboxyl-terminal (C-ter) domain (49) (Supplemen-
tary Figure S10B), whose disordered nature has been well-
conserved (Supplementary Figure S10B–D) despite the
high degree of ordered protein folds expected among ther-
mophilic lifeforms. Notably, amino acids Gly283 and Gly286,
which reside beyond the last structured portion of human
NEIL1 (Phe281 in 10) and are not required for either
glycosylase/lyase or DNA binding activity (50,51), have
been extremely well conserved in all 241 species examined
over the last 500 million years (Figure 6B). Likewise, the
acetyl-acceptor center, weakly discernible in Protostomia
and located just downstream of another highly conserved
residue (Pro290, 93%), evidences strong evolutionary con-
servation across most of the deuterostome lineage. Thus,
the evolutionary conservation of the disordered NEIL1 do-
main, which supports its putative fundamental role in re-
ducing the number of oxidative mutations in cell genomes,
is consistent with an acquired critical role in orchestrating
oxidative DNA damage repair in bilateria, originating ∼500
million years ago during the buildup of free oxygen in the
atmosphere.
DISCUSSION
We find that the map of local variations in mutation rates
among cancer genomes coincides spatially with the map of
chromatin-bound DG AcNEIL1. A fraction of NEIL1 is
acetylated, resulting in its stable integration at selected ge-
nomic loci which, in turn, display lower mutation rates than
loci without the integrated enzyme. This finding implies
that the integrated AcNEIL1 performs local scanning for
DNA damage and repair, likely in the context of functional
BERosomes. The observed loading and stabilization of Ac-
NEIL1 on chromatin is critically dependent upon PTM at
three consecutive lysine residues (Lys297–299), an acetyla-
tion center that appears to be the result of consolidation
among variable amino acids in protostomes, probably oc-
curring during the Cambrian explosion, ∼540 million years
ago, during a transition from sulfur to oxygen as an energy
source. The nesting of the acetylation center within a con-
served intrinsically disordered protein domain is a recurrent
theme for the PTM-mediated regulation of signaling path-
ways and chromatin architecture (52), enabling supramolec-
ular assemblies and liquid–liquid phase transition struc-
tures (53–55), which can organize euchromatin into large
transcriptional hubs (56). Preloading of BER enzymes to
chromatin may be required to access base lesions hidden
within nucleosome-bound DNA (57,58).
Uneven AcNEIL1 mapping along chromosomes defines
three portions of the genome that are differentially targeted
for oxidative damage repair: the active transcriptome, which
is heavily protected; a portion of the genome that is weakly
transcribed and partially protected; and a portion that is not
←−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−
tion. Transcription data were from normal tissues. Data represent mean and SD (vertical bars for mutations and horizontal bars for transcription). The
bin containing TP53 with 45 787 mutations was excluded. (B) Mutation loads in cancer genomes decrease with increasing AcNEIL1 density. Mutations
were computed for 322 1-Mb bins each containing low transcription (0.5–5) as a function of AcNEIL1 ICS. (C) Deconvolution of mutation loads in cancer
genomes into six mutation spectra as a function of transcription at steady AcNEIL1 concentration, from A. Data were fitted to linear regressions with
rates representing dy/dx changes. P-values were from the regression coefficients. (D) Deconvolution of mutation loads in cancer genomes into six mutation
spectra as a function of AcNEIL1 ICS and constant transcription from C. Data were fitted to linear regression with rates representing dy/dx changes.
P-values were from the regression coefficients. (E–G) Genome-wide number of mutations as a function of AcNEIL1 ICS in cancer genomes. (E) G>A; (F)
A>T; (G) A>C. Orange highlight, low AcNEIL1-containing bins enriched in olfactory receptor (OR) genes. (H–J) Genome-wide number of SNPs as a
function of AcNEIL1 ICS in the Swedish population. (H) G>A; (I) A>T; (J) A>C. Orange highlight, low AcNEIL1-containing bins enriched in olfactory
receptor (OR) genes. (K) Relative difference in base changes between cancer genomes and the germline. The percentage base changes occurring in all bins
with low (≤5 × 105) versus high (>5 × 105) AcNEIL1 ICS in cancer genomes subtracted from those in the Swedish population.
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Figure 6. Evolutionary origin of the AcNEIL1 acetylation center. (A) Phylogenetic tree of invertebrate species with (red) and without (black) human
NEIL1 gene homologs, as assessed by blastp. (B) Sequence conservation at the acetylation center in NEIL1 C-ter flexible region. Black, >93% sequence
homology among 241 species; blue, highly conserved lineage-specific amino acids; red, conserved Lys residues carrying the acetylation mark in human
NEIL1.
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at all targeted for repair. This repair pattern appears deeply
engraved into the cellular genetic program and is retained
upon oncogenic transformation. G>A transitions occur in-
dependently of AcNEIL1 localization, and their increase
in incidence as transcription levels increase demonstrates
the vulnerability of the active transcriptome to mutations
and the necessity of an effective repair program to protect
its integrity. C>T (G>A) substitutions occur frequently at
methylated CpG dinucleotides (59), particularly in single-
stranded DNA where deamination of 5-methylcytosine to
thymine, which produces G:T mismatches resulting in mu-
tations (i.e. 5mC:G>T:G>T:A), is accelerated relative to du-
plex DNA (60). C>T transitions also arise from stable cyto-
sine oxidation products, such as 5-hydroxycytosine (61). In
addition, germline homozygous deletions in NTHL1 have
been found to predispose to adenomatous polyposis and
colorectal cancer and to cause an accumulation of C>T
transitions (62), thereby supporting a role for NTHL1 in
the global genome repair of oxidized G:C base pairs (63). 5-
hydroxycytosine is a substrate for NEIL1 in vitro (64); how-
ever, it does not accumulate in Neil1−/− mice (65), in line
with our observation that G>A substitutions do not cor-
relate with NEIL1 occupancy. NEIL2 has been shown to
stably interact with the transcriptional complex (66), and
Neil2−/− mice display increased oxidative DNA damage
in actively transcribed regions relative to wild-type litter-
mates (57). Thus, although ChIP-seq data for NEIL2 are
not yet available, it is conceivable that AcNEIL1 and NEIL2
share portions of the genomic surveillance space. Indeed,
even an intersection of base and nucleotide excision repair
has been seen for oxidative alkylations such as cigarette-
smoke-derived O(6)-4-(3-pyridyl)-4-oxobutylguanine (67),
implying that the pervasive nature of oxidative base dam-
age may select for DG’s to have evolved over-lapping speci-
ficities that allow them to back each other up. Regard-
ing transcription-associated mutagenesis, the tumor sup-
pressor TP53, the most commonly mutated gene associ-
ated with cancer (68,69), strikingly resides within the most
highly transcribed 1-Mb domain in the human genome,
raising the intriguing possibility that susceptibility to hu-
man cancer may stem, in part, from intrinsic genome
architecture.
In a separate Neil1−/− mouse model, 4,6-diamino-5-
formamidopyrimidine (FapyA) and thymine glycol (TG)
base-derivatives displayed the strongest increase relative to
wild-type littermates, followed by 2,6-diamino-4-hydroxy-
5-formamidopyrimidine (FapyG) (70), all of which are val-
idated substrates for NEIL1 (28,71–72). Studies on the mu-
tagenic potential of formamidopyrimidines have suggested
that direct base misincorporation can generate both transi-
tion and transversion mutations (73–75). TG blocks DNA
replication and its bypass, aided by translesion synthesis
polymerases, can yield mutations when Pol is utilized (76).
Nei-like DNA glycosylases exhibit distinct DNA substrate
specificities as compared to the Endonuclease III/Nth fam-
ily of DNA glycosylases. NEIL1 can excise bulky DNA
adducts, such as aflatoxin-Fapy-dG (77), peptide-DNA
crosslinks (78) and cyclo-deoxyadenosines (79). Such bulky
DNA lesions occurring at A:T (leading to A>T,C muta-
tions) and G:C (leading to G>T mutations) base pairs in
transcribed DNA could be repaired specifically by NEIL1,
but not by NTHL1, which would account for the mutator
phenotype observed in NEIL1-deficient mammalian cells
(80). These composite observations are in agreement with
our kinetic rates and genome-wide mutation loads, which
support DNA damage at A:T and G:C base pairs as pre-
ferred substrates for NEIL1 and the antimutagenic role of
AcNEIL1 in human cells.
Besides the active transcriptome, NEIL1 marks the tran-
scriptional origin of ∼1000 genes, including developmen-
tally related genes of the Hox family and members of gene
regulatory networks, such as the polycomb repressive com-
plex 1-like members (CBX8, CBX4 and PCGF3), which
repress Hox expression outside of target tissues (81). Our
analysis that Hox overexpression, and especially AcNEIL1-
containing Hox gene reactivation in low grade glioma, con-
tributes to poor survival strengthens the growing support
for their key role in tumorigenesis (82–84). Neil1−/− (or
Neil2−/−) mouse embryoid bodies display neural defects,
the downregulation of key developmental genes, includ-
ing Hox genes, elevated levels of reactive oxygen species
(ROS) and a pro-apoptotic TP53-associated DNA damage
response (85). Neil1−/− mice that are challenged with ion-
izing radiation also show behavioral and neurological de-
fects (86). ROS, which generate the formamidopyrimidines
NEIL1 substrates (87), increase during neurogenesis, a pro-
cess that is dependent on oxidative phosphorylation (88).
These composite observations support an essential role for
NEIL1 and other BER enzymes in the protection of the de-
veloping embryo from the harmful effects of endogenous
DNA damage, a side effect of tissue differentiation dur-
ing development. The confinement of AcNEIL1 near the
TSSs of weakly expressed genes would, therefore, be con-
sistent with transcriptional repression and the enforcement
of Pol II promoter-proximal pausing (89,90), which would
prevent AcNEIL1 from leaving the promoter area. The al-
tered expression and mutations associated with polycomb
complexes have also been linked to cancer (91,92), and it
will be of interest to determine the extent to which escape
from NEIL1 damage repair beyond the early developmental
stages may contribute to tumorigenesis. The genome-wide
base substitution patterns that are observed between popu-
lation variation and cancer are similar; therefore, notwith-
standing the potential roles played by carcinogens and other
factors during cancer development, endogenous oxidative
DNA damage may represent the strongest source of base
changes for both cancer and population variation, with the
two processes differing quantitatively due to the higher rates
of oxidative stress that occurs in cancer.
In almost one third of the genome, AcNEIL1 peak den-
sity is <25% of that in gene-coding regions, and in ∼80 mil-
lion bp this density is <10%. The genomic domains contain-
ing olfactory receptor (OR) gene family members, a region
to which we mapped the highest mutation rates, is partic-
ularly poor in AcNEIL1 peaks. The OR gene family com-
prises ∼1000 members, in both mouse and human; how-
ever, >50% of these genes have been inactivated in the hu-
man lineage as compared to ∼20% of inactivated genes in
the mouse (93,94). Evolutionary comparisons suggest that
the loss of OR gene expression in primates may have been
driven by anatomical (nose shape and size) and behavioral
(transition from fruit-rich to leaf-rich diet) changes that al-
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leviated the dependency on smell for survival (95). However,
the high frequencies of SNPs in these genomic regions sup-
ports the view that the loss of OR genes is an ongoing pro-
cess in humans and that the lack of oxidative DNA damage
repair by NEIL1 and perhaps other BER enzymes has con-
tributed to this loss.
Besides clarifying a key question in cancer biology re-
lated to the mechanisms underlying the variation in muta-
tion rates in cancer, our work raises several points for future
investigation. Whether PTM-dependent NEIL1 chromatin-
stabilization also enhances its diffusion rates along DNA
(96,97) remains to be explored. Whether the coelution of
NEIL1 with RNA Pol II observed here reflects a func-
tional or casual association also merits further validation,
since NEIL1 maps to both within and outside transcrip-
tional units. In similar vein, the association between early
replication timing and low mutation loads (98) may under-
score an association between BERosomes and replisomes
in euchromatin, where they are abundant and preloaded
on chromatin, but not in heterochromatin (late replica-
tion). This is particularly relevant in the context of NEIL1
given its recognized association with PCNA, FEN1 and
other DNA replication factors (99–102). It will be of in-
terest to assess the contribution of selection pressure in
the context of population variation and differential muta-
tional loads in transcribed versus non-transcribed regions,
as it relates to uneven BERosome occupancy. That endoge-
nous non-acetylated NEIL1 was found both in the cyto-
plasm and the nuclei contrasts with earlier work showing
discrete nuclear localization of C-terminal fluorescently-
tagged NEIL1 in HeLa and U2OS cells (103); an improved
antibody for total-NEIL1, such as one designed against the
key flexible C-terminal region (49) expected to induce mon-
oclonal antibodies that recognize the intract protein (104),
might help resolve such discrepancies. Notably, this same
NEIL1 C-terminal acetylated region is reported to bind
Poly(ADP-Ribose) Polymerase 1 (PARP1) (105), suggest-
ing future NEIL1 localization studies might test the role of
PARylation using PARP1 and poly(ADP-ribose) glycohy-
drolase (PARG) inhibitors (106,107). Because mouse mod-
els support shared substrate specificity for BER enzymes
(108,109), despite distinct physical genomic targets (110),
it will also be useful to determine the relative contribution
of other BER and DNA repair enzymes, such as those asso-
ciated with mismatch repair (111) or with the multi-repair
pathway nuclease XPG associated with both nucleotide and
base excision repair (112), to genome stability. More gen-
erally and illustrating how DG’s may overcome the perva-
sive nature of oxidative DNA base damage by over-lapping
specificities that allow them to back each other up, the inter-
section of base and nucleotide excision repair has been seen
for oxidative alkylations such as cigarette-smoke-derived
O(6)-4-(3-pyridyl)-4-oxobutylguanine (67). This notwith-
standing, the results presented here show that the proto-
typic BER DG NEIL1 is targeted to open chromatin sites
for efficient surveillance and repair of oxidative DNA dam-
age occurring during transcription. Thus, although tran-
scription is DNA damaging due to opening DNA bases
to increased oxidation and deanimation, mutational load
from transcription depends upon repair efficiency, as di-
rectly shown here for NEIL1.
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